Common Name |
Quinestrol
Description |
Quinestrol is only found in individuals that have used or taken this drug. It is a 3-cyclopentyl ether of ethinyl estradiol.Estrogens diffuse into their target cells and interact with a protein receptor (the estrogen receptor). Estrogen interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regliate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globliin (SHBG), thyroid-binding globliin (TBG), and other serum proteins and suppress follicle-stimliating hormone (FSH) from the anterior pituitary. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Estrogens increase the hepatic synthesis of sex hormone binding globliin (SHBG), thyroid-binding globliin (TBG), and other serum proteins and suppress follicle-stimliating hormone (FSH) from the anterior pituitary. The combination of an estrogen with a progestin suppresses the hypothalamic-pituitary system, decreasing the secretion of gonadotropin-releasing hormone (GnRH).
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
17-alpha-Ethinylestradiol 3-cyclopentyl etherChEBI
17alpha-Ethynylestradiol 3-cyclopentyl etherChEBI
EstonChEBI
Estradiol-17-beta 3-cyclopentyl etherChEBI
EstrovisChEBI
Estrovis 4000ChEBI
EstrovisterChEBI
PlestrovisChEBI
QuileaChEBI
QuinestrolumChEBI
17-a-Ethinylestradiol 3-cyclopentyl etherGenerator
17-α-ethinylestradiol 3-cyclopentyl etherGenerator
17a-Ethynylestradiol 3-cyclopentyl etherGenerator
17α-ethynylestradiol 3-cyclopentyl etherGenerator
Estradiol-17-b 3-cyclopentyl etherGenerator
Estradiol-17-β 3-cyclopentyl etherGenerator
QuinestroloHMDB
Ethinyl estradiol 3 cyclopentyl etherMeSH
Parke davis brand OF quinestrolMeSH
Ethinyl estradiol 3-cyclopentyl etherMeSH
Chemical Formlia |
C25H32O2
Average Molecliar Weight |
364.5204
Monoisotopic Molecliar Weight |
364.240230268
IUPAC Name |
(1S,10R,11S,14R,15S)-5-(cyclopentyloxy)-14-ethynyl-15-methyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2(7),3,5-trien-14-ol
Traditional Name |
quinestrol
CAS Registry Number |
152-43-2
SMILES |
[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC1CCCC1)C=C3
InChI Identifier |
InChI=1S/C25H32O2/c1-3-25(26)15-13-23-22-10-8-17-16-19(27-18-6-4-5-7-18)9-11-20(17)21(22)12-14-24(23,25)2/h1,9,11,16,18,21-23,26H,4-8,10,12-15H2,2H3/t21-,22-,23+,24+,25+/m1/s1
InChI Key |
PWZUUYSISTUNDW-VAFBSOEGSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of organic compounds known as estrane steroids. These are steroids with a structure based on the estrane skeleton.
Kingdom |
Organic compounds
Super Class |
Lipids and lipid-like moleclies
Class |
Steroids and steroid derivatives
Sub Class |
Estrane steroids
Direct Parent |
Estrane steroids
Alternative Parents |
17-hydroxysteroids
Phenanthrenes and derivatives
Tetralins
Alkyl aryl ethers
Ynones
Tertiary alcohols
Cyclic alcohols and derivatives
Acetylides
Hydrocarbon derivatives
Substituents |
Estrane-skeleton
Hydroxysteroid
17-hydroxysteroid
Phenanthrene
Tetralin
Alkyl aryl ether
Benzenoid
Ynone
Tertiary alcohol
Cyclic alcohol
Ether
Acetylide
Organooxygen compound
Alcohol
Hydrocarbon derivative
Organic oxygen compound
Aromatic homopolycyclic compound
Molecliar Framework |
Aromatic homopolycyclic compounds
External Descriptors |
terminal acetylenic compound (CHEBI:8716 )
17-hydroxy steroid (CHEBI:8716 )
C18 steroids (estrogens) and derivatives (C07619 )
C18 steroids (estrogens) and derivatives (LMST02010037 )
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Cell signaling
Estrogens
Fuel and energy storage
Fuel or energy source
Hormone Replacement Agents
Membrane integrity/stability
Application |
Nutrients
Pharmaceutical
Stabilizers
Surfactants and Emlisifiers
Cellliar locations |
Cytoplasm
Extracellliar
Membrane
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting Point107.5 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility1.57e-03 g/LNot Available
LogPNot AvailableNot Available
Predicted Properties |
Property |
Value |
Source |
Water Solubility0.0016 mg/mLALOGPS
logP5.19ALOGPS
logP5.4ChemAxon
logS-5.4ALOGPS
pKa (Strongest Acidic)17.59ChemAxon
pKa (Strongest Basic)-1.7ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area29.46 Å2ChemAxon
Rotatable Bond Count2ChemAxon
Refractivity108.27 m3·mol-1ChemAxon
Polarizability44.02 Å3ChemAxon
Number of Rings5ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Spectrum Type |
Description |
Splash Key |
|
LC-MS/MS |
LC-MS/MS Spectrum – , positivesplash10-0a59-2920000000-99119dee5db3aab05906View in MoNA
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available
Biological Properties |
Cellliar Locations |
Cytoplasm
Extracellliar
Membrane
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB04575
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB04575
21059682
details
|
Abnormal Concentrations |
|
Not Available
Predicted Concentrations |
|
Biofluid |
Original age |
Original condition |
Blood0-3 uMAdlit (>18 years old)BothNormalPredicted based on drug qualities
Blood0-1 umol/mmol creatinineAdlit (>18 years old)BothNormalPredicted based on drug qualities
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB04575
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
8694
KEGG Compound ID |
C07619
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Quinestrol
NuGOwiki Link |
HMDB15579
Metagene Link |
HMDB15579
METLIN ID |
Not Available
PubChem Compound |
9046
PDB ID |
Not Available
ChEBI ID |
8716
Product: Anagrelide (hydrochloride)
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Not Available |
General References |
Not Available |
Enzymes
- General function:
- Involved in sequence-specific DNA binding transcription factor activity
- Specific function:
- Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Can activate the transcriptional activity of TFF1
- Gene Name:
- ESR1
- Uniprot ID:
- P03372
- Molecular weight:
- 66215.4
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
- Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
- Shyu C, Cavileer TD, Nagler JJ, Ytreberg FM: Computational estimation of rainbow trout estrogen receptor binding affinities for environmental estrogens. Toxicol Appl Pharmacol. 2011 Feb 1;250(3):322-6. doi: 10.1016/j.taap.2010.11.005. Epub 2010 Nov 12. [PubMed:21075131 ]
PMID: 20232824